BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35851959)

  • 21. Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients.
    Hutt D; Bielorai B; Baturov B; Z'orbinski I; Ilin N; Adam E; Itzhaki O; Besser MJ; Toren A; Jacoby E
    Transfus Apher Sci; 2020 Aug; 59(4):102769. PubMed ID: 32414613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis.
    DeSimone RA; Myers GD; Guest EM; Shi PA
    J Clin Apher; 2019 Aug; 34(4):487-489. PubMed ID: 30489654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study.
    Ikeda K; Minakawa K; Muroi K; Fujiwara SI; Yamada-Fujiwara M; Fujimori Y; Tanosaki R; Ohto H;
    Transfusion; 2016 Nov; 56(11):2839-2847. PubMed ID: 27572290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: A single center report of 39 procedures.
    Sanderson F; Poullin P; Smith R; Nicolino-Brunet C; Philip P; Chaib A; Costello R
    J Clin Apher; 2017 Jun; 32(3):182-190. PubMed ID: 27442837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor-T cell manufacture.
    Tyagarajan S; Schmitt D; Acker C; Rutjens E
    Cytotherapy; 2019 Dec; 21(12):1198-1205. PubMed ID: 31837735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report.
    Schultz L; Patel S; Davis KL; Ramakrishna S; Sahaf B; Bhatia N; Baggott C; Erickson C; Majzner RG; Oak J; Bertaina A; Mackall C; Feldman S
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32929049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.
    Leone G; Baldini V; Bramanti S; Crocchiolo R; Gattillo S; Ermini S; Giudice V; Ferrero I; Moscato T; Milani R; Gozzer M; Piccirillo N; Tassi C; Tassi V; Coluccia P
    Blood Transfus; 2023 Nov; 21(6):514-525. PubMed ID: 37146295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.
    Qayed M; McGuirk JP; Myers GD; Parameswaran V; Waller EK; Holman P; Rodrigues M; Clough LF; Willert J
    Cytotherapy; 2022 Sep; 24(9):869-878. PubMed ID: 35718701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection.
    Chung Y; Kong JH; Hu Y; Lee SN; Shim H; Eom HS; Kong SY
    J Clin Apher; 2021 Feb; 36(1):28-33. PubMed ID: 32882095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
    Jo T; Yoshihara S; Okuyama Y; Fujii K; Henzan T; Kahata K; Yamazaki R; Takeda W; Umezawa Y; Fukushima K; Ashida T; Yamada-Fujiwara M; Hanajiri R; Yonetani N; Tada Y; Shimura Y; Nishikii H; Shiba N; Mimura N; Ando J; Sato T; Nakashima Y; Ikemoto J; Iwaki K; Fujiwara SI; Ri M; Nagamura-Inoue T; Tanosaki R; Arai Y
    Br J Haematol; 2023 Jul; 202(2):256-266. PubMed ID: 37096915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
    Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
    J Clin Apher; 2001; 16(2):82-7. PubMed ID: 11746533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems.
    Schulz M; Bialleck H; Thorausch K; Bug G; Dünzinger U; Seifried E; Bönig H
    Transfusion; 2014 Jun; 54(6):1622-9. PubMed ID: 24299303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous Mononuclear Cell Collection (cMNC) protocol impact on hematopoietic stem cell collections in donors with negative collection predictors.
    Bartnik K; Maciejewska M; Farhan R; Urbanowska E; Król M; Król M; Feliksbrot M; Wiktor-Jędrzejczak W; Snarski E
    Transfus Apher Sci; 2018 Jun; 57(3):401-405. PubMed ID: 29778714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture.
    O'Reilly MA; Malhi A; Cheok KPL; Ings S; Balsa C; Keane H; Jalowiec K; Neill L; Peggs KS; Roddie C
    Cytotherapy; 2023 Mar; 25(3):323-329. PubMed ID: 36513573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: first-time collection results and evaluation of subsequent cryopreservation.
    Steininger PA; Smith R; Geier C; Zimmermann R; Eckstein R; Strasser EF
    Transfusion; 2013 Apr; 53(4):747-56. PubMed ID: 22803702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19
    Teoh J; Brown LF
    Cytotherapy; 2022 Sep; 24(9):962-973. PubMed ID: 35610089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
    Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
    Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timely Leukapheresis May Interfere with the "Fitness" of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients.
    Farina M; Chiarini M; Almici C; Accorsi Buttini E; Zuccalà F; Piva S; Volonghi I; Poli L; Bernardi S; Colnaghi F; Re F; Leoni A; Polverelli N; Turra A; Morello E; Galvagni A; Moratto D; Brugnoni D; Cattaneo C; Ferrari E; Bianchetti A; Malagola M; Re A; Russo D
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance prediction algorithm for autologous PBSC collection in adults and pediatric patients using large volume leukapheresis.
    Bojanic I; Besson N; Vidovic I; Cepulic BG
    J Clin Apher; 2019 Aug; 34(4):407-415. PubMed ID: 30829422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
    Pettengell R; Morgenstern GR; Woll PJ; Chang J; Rowlands M; Young R; Radford JA; Scarffe JH; Testa NG; Crowther D
    Blood; 1993 Dec; 82(12):3770-7. PubMed ID: 7505124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.